TRIVERAM cpr pell 20/5/5mg bte 30 pce

7680655140035 CH-65514 C10BX11 02.07.2.

Reimbursement limitations:

TRIVERAM

Le remboursement s'applique aux patients adultes correctement contrôlés avec périndopril, amlodipine et atorvastatine pris simultanément …

TRIVERAM cpr pell 20/5/5mg bte 30 pce
TRIVERAM cpr pell 20/5/5mg bte 30 pce
TRIVERAM cpr pell 20/5/5mg bte 30 pce
1 / 3
google

Details

Product number
6551402
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
atorvastatinum 20 mg ut atorvastatinum calcicum trihydricum 21.64 mg, perindoprilum argininum 5 mg corresp. perindoprilum 3.395 mg, amlodipinum 5 mg ut amlodipini besilas 6.935 mg, calcii carbonas, lactosum monohydricum 54.92 mg, cellulosum microcristallinum, carboxymethylamylum natricum corresp. natrium 0.5 - 0.75 mg, hydroxypropylcellulosum, maltodextrinum, magnesii stearas, pellicule: glycerolum, hypromellosum, macrogolum 6000, magnesii stearas, E 171, E 172 (flavum), pro compresso obducto.

Articles (1)

Triveram 20 / 5 / 5 mg, comprimé pelliculé
Tabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/05/2025
Patient information leaflet
Français
23/05/2025
Patient information leaflet
Italien
23/05/2025
Professional SmPC
Allemand
23/05/2025
Professional SmPC
Français
23/05/2025
Professional SmPC
Italien
23/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
21.64 MG Substance WIZUS
(N/A)
5.0 MG Substance WIZUS
(N/A)
3.395 MG Substance Wirkstoff (Principe actif)
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
6.935 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
54.92 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 43.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2016

Authorization holder

Servier (Suisse) SA

1202 Genève

Authorization information

Swissmedic authorization number
65514
Drug name
Triveram, comprimés pelliculés
Galenic form
FILM
ATC Code
C10BX11
Authorization status
Z
Dispensation category
B
First authorization
23/06/2016
Authorization expiration date
31/12/9999
IT number
02.07.2.
Domain
Human medicine

Packaging details

Description (FR)
TRIVERAM cpr pell 20/5/5mg bte 30 pce
Description (DE)
TRIVERAM Filmtabl 20/5/5mg Ds 30 Stk
Market launch
23/06/2016
Narcotic (BTM)
No

Other packaging sizes

TRIVERAM cpr pell 10/5/5mg bte 30 pce
30 TABL
View
TRIVERAM cpr pell 10/5/5mg 3 bte 30 pce
90 TABL
View
TRIVERAM cpr pell 20/5/5mg 3 bte 30 pce
90 TABL
View
TRIVERAM cpr pell 20/10/5mg bte 30 pce
30 TABL
View
TRIVERAM cpr pell 20/10/5mg 3 bte 30 pce
90 TABL
View
TRIVERAM cpr pell 20/10/10mg bte 30 pce
30 TABL
View
TRIVERAM cpr pell 20/10/10mg 3 bte 30 pce
90 TABL
View
TRIVERAM cpr pell 40/10/10mg bte 30 pce
30 TABL
View
TRIVERAM cpr pell 40/10/10mg 3 bte 30 pce
90 TABL
View